Advances in cancer immunotherapy

Research output: Contribution to journal › Short survey/review › Contributed › peer-review

Contributors

  • Detlef Ockert - , TUD Dresden University of Technology (Author)
  • Marc Schmitz - , Institute for Immunology, TUD Dresden University of Technology (Author)
  • Monika Hampl - , TUD Dresden University of Technology (Author)
  • Ernst Peter Rieber - , TUD Dresden University of Technology (Author)

Abstract

Specific engagement of immune effector functions is a rapidly advancing field within experimental tumor therapy. A recent meeting focused on the analysis of cellular and humoral immune responses against tumors and on clinical trials of antitumor vaccination and antibody therapy.

Details

Original languageEnglish
Pages (from-to)63-65
Number of pages3
JournalImmunology Today
Volume20
Issue number2
Publication statusPublished - 1 Feb 1999
Peer-reviewedYes

External IDs

PubMed 10098323

Keywords

Sustainable Development Goals

ASJC Scopus subject areas